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Chapter 1 
 
Introduction 
 
1.1 Available treatment options using photons and their interaction 
processes 
External beam radiation therapy is a mainstay of treatment option in the treatment of 
malignant tumors, the other commonly used options being surgery, chemotherapy, and 
brachytherapy.  External beam radiation therapy mainly uses Bremsstrahlung photons 
produced when highly accelerated electrons are incident on a target of high atomic 
number, gamma rays produced by radionuclides, and electron beams.  The use of heavy 
particle beams (C-12, protons, etc.) is increasing as they offer radiobiological advantage 
over photon beams, due to their short ranges and the sharp dose fall-off beyond their 
maximum range.     
In the mega-voltage range of photon beams, the desired biological effect of bond-
breaking and hence cell damage of the tumor cells is brought about primarily by the 
incident photons losing their energy to the tissues of the human body by Compton 
scattering, pair production and photo disintegration.  Photoelectric absorption also 
contributes but little to the energy loss of the incident photons of the mega-voltage range. 
Enhancing the local dose delivered by enhancing photonuclear disintegrations offers the 
possibility of increasing the dose to the tumor (for the same delivered dose) by 
introducing secondary charged particles in the irradiated region.  The dose delivered by  
 2 
 
 
secondary charged particles from the photo nuclear disintegrations that occur in the 
range of energies available in bremsstrahlung spectrum of photons was attempted to 
measure to explore the feasibility of local dose enhancement due to photo nuclear 
disintegrations.    
 
 
1.1.1 Photoelectric absorption: 
 
The incident photon interacts with an atom and loses all of its energy to the atom.  The 
energy absorbed by the atom is imparted as kinetic energy to an orbital electron, which 
leaves the atom in an excited and ionized state.  The atom returning to ground state is 
accompanied by emission of characteristic x-rays and / or Auger electrons.  
For photon energies that don’t lead to highly relativistic photo electrons, the mass 
attenuation co-efficient (i.e) the beam fraction removed by unit areal density has been 
calculated to increase as the fifth power of atomic number of the interacting medium and 
decrease as the seven half power of the energy of the incident photon.
1
  


 
For an interacting medium of low atomic number like tissue with an effective atomic 
number of 7.4, photo electric effect is negligible with incident photon energies above 
200 KeV.  In this range of photon energies which are used in radiation therapy, the photo 
electrons, if they are emitted are relativistic.   
 
 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-1. Mass attenuation coffecient (τ/ρ) vs. photon energy curves for water (Zeff = 7.42) and for lead (Z 
= 82).
2 
 
 
 
The mass photoelectric attenuation coefficient (τ/ρ) plotted against photon energy, on a 
logarithmic scale shows that for water representing a low atomic number similar to tissue, 
the graph is almost a straight line with a slope of approximately -3.   
 
 4 
 
Experimental data for various materials show that the attenuation coefficient depends on 
the third power of the atomic number of the interacting medium and decreases as the 
third power of the energy of the incoming photon.
2 

 
 
 
1.1.2 Compton scattering: 
               
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1-2.  Compton scattering 
 
 
As the photon energy is further increased, the incident photon interacts with a free 
electron i.e. an orbital electron whose binding energy is negligible compared to the 
energy of the photon.  Part of the incident photon’s energy is imparted to the electron  
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which gets emitted from the atom, and the photon scatters with reduced energy.  The 
lower energy scattered photon is likely to interact with the medium again.   
Because this interaction involves free electrons in the absorbing medium, Compton mass 
attenuation co-efficient (is independent of atomic number, Z and is dependent on 
the electron density of the medium.  Number of electrons per gram is about the same  
(3 x 10
23
 electrons per gram) for elements that are of biological interest except hydrogen 
which has an electron density of 6 x 10
23
 electrons per gram because of having no 
neutrons in its nucleus.   
 
 
1.1.3 Pair production 
 
When a high energy photon (E > 1.02 MeV) is in the vicinity of a nucleus, some of the 
incident photon energy can be converted into the rest masses of an electron-positron pair.  
This would then result in the complete absorption of the photon and the emission of an 
electron and a positron.  According to mass-energy equivalence, the rest mass of an 
electron or a positron corresponds to energy of 511 KeV.  All of the energy of the 
incident photon, in excess of 1.02 MeV (needed to create the electron-positron pair) is 
imparted to the pair as kinetic energy with the exception of a very small amount going 
into the recoiling nucleus. 
The electron and the positron, cause excitations and ionization along their range, 
delivering dose locally.  When the positron reaches thermal velocity, it annihilates with 
an electron, emitting two photons of energy 511 KeV each.    
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   Fig. 1-3.  Pair production 
 
    
 
Because this is an interaction that involves the electric field of the nucleus, the 
probability of pair production increases rapidly with atomic number, Z of the interacting 
material.  It varies with Z
2
 per atom (and approximately Z per gram).
3
  The probability 
for pair production increases remarkably as the photon energy is increased beyond the 
threshold of 1.02 MeV up to about 20 MeV as shown below in figure 1-4.   
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Fig. 1-4.
   
  Total photon cross section σtot in tissue, as a function of photon energy, showing the  
contributions of different processes: τ, photo electric effect; σcoh, Rayleigh scattering; σincoh, Compton 
scattering off an electron; κn, pair production, nuclear field; κe, pair production, electron field; σph, 
photonuclear absorption.
4 
 
 
1.1.4  Photo disintegration 
When the incident photon has enough energy to remove a nucleon from a nucleus, the 
absorbing nucleus undergoes photodisintegration.  The nuclear binding energy being in  
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the range of 8 MeV or more (except for the lightest elements), this interaction process 
has a threshold of about 8 MeV.  At moderate energies, reactions like (γ,p), and (γ,n) are 
initiated.  When the incident photon energy is 10 MeV or higher, reactions like (γ,np), 
(γ,2n), and (γ,αn) are observed.   
Cross-section for photo disintegration is usually neglected in calculating the energy 
removed from a photon beam because the cross-sections are small under all 
circumstances (usually measured in milli barns).  They tend to have a sharp threshold, 
rise to a maximum at 3 to 6 MeV above the threshold and decrease at higher energies.
5 
 
(γ,n) reactions 
When the incident photon has energy more than the nuclear binding energy, the 
oscillating electric and magnetic fields of the photon can cause excitation of the nucleus.  
The nucleus decays by various methods, one of which is neutron emission. 
A neutron being emitted from the nucleus leaves it proton-rich as a result of the (γ,n) 
reaction.     
   ZX
A
 (,n)   ZX
A-1
  +  0n
1
 
 
These proton-rich nuclei decay by positron (β+) emission, leaving a flux of positrons and 
neutrons at the site of their production. 
   1p
1    0n
1
  +  +1
0
  +   
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The neutrons, being uncharged are long-range particles and are unlikely to interact 
locally and hence contribute little to the local dose.  The positrons cause ionizations 
along their range, and hence deliver dose, before attaining thermal velocities and 
interacting to produce two 511 KeV annihilation photons. 
 
16
O (γ,n) 15O reaction 
When this (,n) reaction happens with the stable oxygen atoms in tissue and in bone, it 
leaves behind radioactive 
15
O. 
 
8O
16
  (,n)    8O
15
  +  0n
1
 
 
15
O decays with a half-life of 2.1 minutes to 
15
N by positron emission.
6 
 
8O
15
    7N
15
  +  +1
0
  +   
 
The positrons emitted share the available kinetic energy with the neutrinos, which results 
in their energy being a spectrum with an end-point energy that corresponds to the 
difference in the rest mass energy between the initial nucleus and the end products of the 
reaction, assuming that the recoil kinetic energy of the initial nucleus is negligible.  This 
difference, for the above reaction, gives a maximum energy of 1.73 MeV for the 
positrons.   
 
  
 10 
 
 
 
 
 
 
 
 
 
 
                       Fig. 1-5.  spectrum of positron energy
7 
 
Figure 1-5 shows the spectrum of positron energy of the 
16
O (γ,n) 15O reaction, with a 
maximum energy of 1.7 MeV and an average energy of 719.9 KeV. 
 
The reaction cross section versus energy curve shown in figure 1-6 had been obtained by 
the least-structure analysis of photonuclear yield functions, the number of photonuclear 
transitions (as evidenced by detection of the resultant nucleons or by counting the 
resultant activity per unit incident energy at a particular Bremsstrahlung energy) as a 
function of energy.  The data had been acquired in energy intervals of 125 KeV.  The 
numbered peaks had occurred consistently in all cross sections derived from individual 
yield functions.
8
  Cross section of 2 milli barns and lower had been measured up to 
photon energy of 63 MeV, for this reaction.   
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Fig. 1-6.  Cross section vs. photon energy for the O
16(γ,n)O15 reaction8 
 
 
 
The experimental methods for producing beams of monoenergetic photons used for 
photonuclear reaction studies include annihilation in flight of fast positrons, tagged 
bremsstrahlung
9,10
, and gamma rays from the capture of protons or neutrons.
11
 
 
 
 
 12 
 
The graph of reaction cross section versus photon energy shown in figure 1-7 was 
obtained by the use of monoenergetic photons from in-flight annihilation of fast 
positrons. 
 
 
 
 
 
 
 
 
 
 
 
 
     
  Fig 1-7.  Cross-section vs. photon energy for the O
16(γ,n)O15 reaction12 
 
 
The threshold for this interaction, as seen from figures 1-6 and 1-7 for the O
16(γ,n)O15 
reaction is 15.5 MeV.  The reaction has resonances at various higher energies with a 
maximum cross section of 15 milli barns around 22 MeV.  Considering errors in 
counting statistics, calibration, geometry, and numerical analysis, and assuming random 
occurrence of these errors, there would be an error of up to 20% in the quoted values. 
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12
C (γ,n) 11C reaction 
When this (,n) reaction happens with the stable carbon atoms in tissue and in bone, it 
leaves behind radioactive 
11
C. 
6C
12
  (,n)    6C
11
  +  0n
1
 
 
11
C decays with a half-life of 20.1 minutes to 
11
B by positron emission.
13 
 
6C
11
    5B
11
  +  +1
0
  +   
 
Giant dipole resonance 
Giant dipole resonance is an interaction of the electric field of the incident photon and 
the protons in the nucleus.  It is a photo disintegration process where the protons 
oscillate in response to the alternating electric field of the photon.  The neutrons being 
uncharged are not influenced by the electric field of the incident photon, but being bound 
to the protons by nuclear force oscillate 180 degrees out of phase with the protons.  
When this oscillation gains enough amplitude, the nucleus spallates emitting one or more 
nucleons.    
If protons are emitted from the nucleus, the (γ,p), (γ,2p) or (γ,3p) reactions leave behind 
proton-deficient nuclei which decay by negatron (β-) emission.   
   ZX
A
 (,p)   Z-1Y
A-1
  +  1p
1
 
Neutrons being emitted from the nucleus will produce proton-rich nuclei which decay by 
positron (β+) emission.  
   ZX
A
 (,n)   ZX
A-1
  +  0n
1
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        Fig. 1-8.
 
Resonant energy (MeV) for giant dipole resonance vs. atomic mass number
14 
 
 
For calcium, with a mass number of 40, the resonance is expected around 18-25 MeV as 
seen from the above figure.  Giant dipole resonance of Ca-40 with photons of resonant 
energy would leave behind radioactive Ca-39 which decays with a half-life of 0.9 
seconds
15
.     
   20Ca
40
 (,n)   20Ca
39
  +  n
1
 
   
 
These radioactive Ca-39 nuclei decay by positron emission to ground state.   
 
20Ca
39    19K
39
  +  +1
0
  +   
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The positron emission due to the photo nuclear disintegration processes mentioned above 
is not a prompt event.  In the time between the photon's incidence and the positron's 
emission, the vibrating nucleus loses information on the direction of the photon's 
incidence which makes the direction of emission of the positron uncorrelated with the 
direction of incidence of the photon.  The source (i.e) the radioactive nucleus being at 
rest and the direction of emission of the positron being uncorrelated to the direction of 
the incidence of the photon, the positrons due to the photo nuclear disintegration 
processes will be emitted isotropically.  Although the main local dose production will be 
from the positron flux, the endpoint annihilation photons (0.511 MeV) will also deposit 
dose in the biological material.   
 
 
All of the common processes by which photons give up their energy involve the 
production of electrons and/or positrons.  Though every molecule can be potentially 
subjected to radiation damage, only when there is more than one ionization produced 
within the molecular dimension, is the radiation damage lethal.  Single distant 
ionizations do not contribute to cell damage (because of various cell-repair mechanisms) 
and hence dose, but contribute to the loss of energy of the incident radiation.   
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1.2  Doping techniques 
All of the interaction processes mentioned above depend on the energy of the incident 
photon with some of them depending on the atomic number of the interacting medium 
also.  Human tissue, with its effective atomic number of 7.64 presents a rather low 
atomic number medium to the interacting photons, an issue that is addressed by doping 
techniques like Neutron Capture Therapy and other techniques that selectively enhance 
absorbed dose in the tumor by concentrating a high atomic number material in the tumor. 
 
 
1.2.1  Neutron Capture Therapy 
The therapeutic possibilities of neutrons was postulated by Locher in 1936.
16
  The 
technique of neutron capture therapy involves tagging the tumor with a capture agent 
which compared to other elements present in tissue such as hydrogen, oxygen, nitrogen, 
etc., has a much higher cross section to interact with neutrons. The tumor is then 
irradiated with thermal neutrons.  The neutrons interacting with the capture agent result 
in the emission of charged particles which deliver dose locally to the tumor, with 
minimal dose to the surrounding normal tissue. 
Some possible neutron capture agents that have been studied include 
10
B, 
7
Li, and 
235
U 
(radioactive) with cross sections respectively of 3838 barns, 941 barns, and 583 barns for 
thermal neutron capture.  
157
Gd has the highest thermal neutron capture cross section of  
stable nuclides, at 255,000 barns.  
135
Xe with a cross section of 2,720,000 barns for 
thermal neutrons is an inert gas and is radioactive. 
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Boron Neutron Capture Therapy 
Boron-10, a non-radioactive isotope of boron has been the capture agent of choice for 
neutron capture therapy, because of its abundance (it comprises approximately 20% of 
naturally occurring boron), availability, non-toxicity, well understood chemistry, and the 
fact that B-10 has a cross section of about 3848 + 38 barns for neutrons of 0.025 eV.
17
  It 
can be preferentially absorbed by the tumor when the tumor is tagged with a drug 
containing boron-10 and tumor seeking compounds.   
A boron-10 nucleus that absorbs a neutron emits a highly energetic alpha particle and a 
lithium ion.    
  (
10B,n) → 7Li + 4He + γ       
The alpha particle and the lithium ion are of short range and high linear energy transfer 
(LET) which is the average energy lost by a particle over a given track length.  Their 
combined path lengths approximates to about 12 microns, one cell diameter – this limits 
the effects of ionizing radiation to those cells that have been tagged with a sufficient 
amount of 
10
B, thus sparing the surrounding normal cells. 
 
Unlike photons or electrons, alpha particles, with their high LET, can cause bond 
breaking and hence, cell damage to hypoxic and well-oxygenated tumor cells alike.  
They also cause damage to actively dividing and inactive cells alike.  Though the tumor 
is irradiated with an external beam of neutrons, the alpha particles that are released from 
within the tumor are the primary dose carriers in this technique. 
 
 18 
 
Gadolinium neutron Capture Therapy 
Gadolinium-157, with a cross-section of about 255,000 barns for thermal neutrons is 
being studied as a capture agent
18
, having the advantage of being already used as a 
clinical agent providing contrast for  magnetic resonance imaging. 
The (n, γ) reaction is accompanied by the emission of internal conversion electrons and 
gamma-induced Auger electrons of varying energy
19
 
(
157Gd,n) → 158Gd + γ 
The low energy Auger electrons provide high LET-type damage within a mean free path 
of 12.5nm from within the target tissue causing a locally intensive destruction in the 
DNA of the tumor cells.
20
 
 
The efficacy of neutron capture therapy depends on the selective accumulation of the 
capture agent in the tumor tissue compared to the surrounding healthy tissue.  Various 
tumor selective Boron / Gadolinium containing clinical agents are being investigated.
21
  
Studies are also being conducted to detect the prompt gamma rays of the reaction for 
imaging and hence being able to monitor the uptake region during treatment.
22
 
 
1.2.2  Enhancing dose by introducing high atomic number material in the treatment 
region 
External radiation therapy techniques like intensity modulated radiation therapy offer 
dose conformity to the target volume.  Additional dose conformity and enhancement can 
be achieved by preferentially increasing the contrast and hence dose inhomogeneity 
between the tumor and surrounding normal tissue. 
 19 
 
 
 
Dose enhancement by photo electric absorption 
Dose enhancement due to photoelectric absorption of kilovoltage x-rays in elements of 
atomic number higher than that of tissue had been observed in patients with 
reconstructive metal implants receiving radiation therapy for mandibular and head and 
neck cancers, at the metal-tissue interface.
23,24
  High atomic number elements have been 
introduced into the tumor to enhance the local dose by photo electric absorption.  Dose 
enhancing agents that have been investigated include iodine (Z=53), gadolinium (Z=64), 
and gold (Z=79).
25
    Gold, with its high atomic number and biocompatibility
28
, has been 
studied extensively in the form of nanoparticles and microspheres, to preferentially 
increase absorbed dose in the tumor.
26-29
  With gold nanoparticles, an order of magnitude 
reduction in the delivered dose has been achieved to deliver the same target dose without 
the nanoparticles.
29
  Comprehensive characterization of cellular responses to the 
nanoparticles is needed in further assessing their dose enhancing potential in radiation 
therapy. 
 
The use of flattening filter free (FFF) 6 MV beam has the potential to offer more dose 
enhancement compared to that of a flattened beam.
30
  The FFF beam which has a higher 
prevalence of lower energy (KeV) photons compared to that of a conventional flattened 
beam, has a higher percentage of photons at the absorption edge energies of the 
enhancement elements used, increasing the probability of photoelectric absorption.  
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Dose enhancement by pair production 
With megavoltage photon beams, photon energies of more than 1.02 MeV are available 
in radiation treatment units.  This brings in the possibility of using pair production as the 
mechanism by which the photon energy is transferred to the interacting human tissue.  
The probability of pair production, which depends on the square of the atomic number (Z) 
of the interacting material, increases remarkably as the photon energy is increased up to 
20 MeV as highlighted in figure 1- 4.  This probability can be further increased by 
introducing a high atomic number material in the treatment region.    
Local dose enhancement of as much as 40% has been achieved by introducing gold 
(Z=79) foils in the treatment region.  In vivo study of this finding is being done by 
injecting submicron gold particles into the tumor.
31 
 
1.2.3  Tumor-targeting radiopharmaceuticals 
A radionuclide with its known type of emitted radiation is carried to the tumor by a 
tumor-seeking carrier.
32
  If the range of the emitted radiation is within the tumor, the 
given dose is restricted to within the tumor, providing a localized radiation dose, from 
within the tumor, sparing the surrounding normal tissue.  The potential use of various 
liposomes, micelles, microspheres and capsules, etc. as carriers is being investigated.
33
  
Nanoparticles of several nature including quantum dots, colloidal gold, super 
paramagnetic iron oxide crystals, etc. that contain both therapeutic components and 
multimodality imaging labels are being studied for efficient and specific in vivo delivery 
of the pharmaceutical and for accurate quantitative assessment of the therapeutic efficacy 
 21 
 
noninvasively over time.
32
  The choice of the radiopharmaceutical would depend on the 
range and linear energy transfer (LET) of the type of emitted radiation and the half-life 
of the radioactive isotope.  The use of magnetic fields to shorten the range of the 
positrons and hence to restrict the dose to only the tumor has also been investigated.
34
 
 
Metabolic Radiation Therapy 
Radionuclides that intervene in the metabolism of a cell (i.e) in the mechanism of its 
biological functioning, can be used for therapeutic purposes since their damaging effect 
will operate within the actual cell itself.
 
 
131
I has long been an effective tool for metabolic 
radiation therapy.  Strontium 89, Rhenium 186, and Samarium 153 are some of the 
radiopharmaceuticals that are being studied for their effectiveness or lack of it in 
metabolic radiation therapy.
35 
 
 
1.3  Advantages of local dose enhancement in external beam radiation 
therapy  
The goal of radiation therapy is to deliver a lethal dose to the tumor while keeping dose 
to surrounding normal tissue as low as possible.  Figure 1-7 shows the graph of the 
probability for cure against the dose delivered to tumors of various sizes.  The steepness 
of the curves shows that a small increase in dose makes a significant increase in the cure 
probability. 
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Fig.1-9. The probability of eradicating the tumor as a function of dose for tumors containing 10
6
, 10
8
, 10
10
,  
 and10
12 
cells.
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A limitation of radiation therapy is the potential for toxicity to neighboring normal 
tissues at an effective dose that offers a high probability for cure, as shown in figure 1-8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1-10.The probability of curing the tumor and the probability of unacceptable damage to normal 
  tissue vs. dose for a tumor and normal tissue containing 10
8
 cells.
28 
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As seen from the graph, in order to have a high probability for cure, a minimum of 60 
Gray delivered to the tumor is required.   When the dose is higher than about 63 Gray, 
there is unacceptable damage to surrounding normal tissue. 
 
When a resonance process that enhances local dose is maximized by using the 
appropriate energy photons, for a lower delivered dose, the dose to the target can be 
increased, keeping dose to surrounding normal tissue to a minimum.   
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Chapter 2 
 
Experiment 
 
 
 
2.1  Planned procedure for the experiment 
A known quantity of a calcium compound or bone is to be irradiated using a beam 
produced at the 25MV setting.  Photons are incident on a time pick off unit (fig. 2-2) 
mounted on to the collimator.  When this unit signals the end of incident photon flux, a 
radiation time monitor (sec. 2.1.3) enables the multi-channel analyzer to start analyzing 
as soon as the irradiation was complete.  The decay products resulting from the 
interactions of the incident photons with the atoms of the irradiated object will be 
analyzed using a NaI scintillator coupled with a photomultiplier whose signals are 
analyzed by the multi-channel analyzer in energy mode in order to detect 511 KeV 
photons.  The 511 KeV photons produced due to the annihilation of the positrons that are 
products of giant dipole resonance between Ca-40 and photons of resonant energy would 
be detected after the beam has been turned off (unlike the positrons produced due to pair 
production, during irradiation).     
 The same procedure is to be repeated a second time with the analyzer now 
working in the time mode, with its energy discriminator set for 511 KeV.  The decay of 
511 KeV photons measured against time is the decay of positrons emitted due to giant 
dipole resonance after the beam had been turned off.  A time analysis of this decay would 
indicate which radioactive nucleus is decaying by positron emission. 
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2.1.1  Filter to absorb the lower energy photons 
The photon beam from the linear accelerator contains a Bremsstrahlung spectrum of 
energies ranging from zero to a maximum of the accelerating voltage of the electrons.  
Since the lower energy photons (in the Bremsstrahlung spectrum and Compton scattered 
photons) do not contribute toward activating the resonance, but toward the externally 
delivered photon dose (and hence not to the dose enhancement), it is desired to 
preferentially remove the lower end of the spectrum.  
 
 A 3.4 mm thick lead sheet was used to absorb the lower energy photons scattered 
from the collimator jaws.  At very low energy like 0.25 MeV, the lead atoms present a 
high cross-section of 191 barns/atom
37
, which corresponds to 90% absorption of this 
energy photons.  As can be seen from figure 2-1, photons of energy lower than this have 
higher cross-sections and are heavily suppressed.  As the cross-section increases slowly 
beyond 5 MeV, a better option is discussed in section 5.2.1. 
 
 
  
 
 
 
 
 
 
     Fig. 2-1.  Total photon attenuation cross-section in lead as a function of photon energy
37 
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2.1.2   Output of the linear accelerator 
A Varian linear accelerator model 2300cd, with maximum available photon energy of 25 
MeV was used for the experiment.  The pattern of the output signal of the linear 
accelerator had to be observed in order to design the radiation time monitor, which will 
enable the analyzer as soon as the beam had been turned off after having been on. 
 
Signals observed   
In order to see the pattern of the output of the linear accelerator, a set up as shown in the 
block diagram below was used.  
  
  Fig. 2-2.  Block diagram of the set up to observe the output of the linear accelerator. 
 
The time pick-off unit (TPU) shown in figure 2-2, a device previously constructed, was  
mounted on to the collimator of the linear accelerator.  It consists of a light-tight box 
with its window made of pure aluminum to avoid any long-lived radioactive isotopes and 
is painted white inside for maximum reflection.  It has a sheet of a plastic scintillator 
(NE102) at 45 degrees and a side-on photo multiplier tube (1P28) as shown in figure 2-2. 
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   Fig. 2-3.  Time pick-off unit. 
 
The high voltage power supply that maintains the cathode of the photo multiplier at a 
high negative voltage with respect to the anode was outside the treatment room and the 
voltage input to the photomultiplier was done by a long cable passed beneath the door of 
the treatment room.  The output of the photomultiplier was observed on an oscilloscope 
which was also outside the treatment room and was connected to the time pick-off unit 
by a long cable passed beneath the door. 
As long as there are photons interacting with the scintillator of the time pick-off unit, (i.e) 
as long as the primary beam is on, the output was observable as a voltage difference on 
the oscilloscope.  The following figure shows the observed output of the linear 
accelerator for a 25MV beam at a dose rate of 600 MU/min. 
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  Fig. 2-4. Output of the linear accelerator vs. time 
 
As seen in figure 2-4, the output of the linear accelerator was found to be pulsed with 
occasional longer stretches of noise in between the pulses.  Increasing or decreasing the 
dose rate resulted in the pulses being closer together or farther apart.  The signal 
produced by the activation products was not visible compared to that produced by the 
primary photons. 
It can also be seen that the discharge time for the pulses was about 2 milli seconds which 
is considerably longer than the rise time due to the stopping transient being longer than 
the starting transient.  It is important to start counting decay activity immediately after 
 29 
 
the beam had been turned off because of the short half-lives of the decay products 
involved.  A longer stopping transient would mean a delay in signaling of the beam 
having been turned off, which in turn, would delay the starting of the counting of decay 
activity.  Having ruled out activation in the aluminum window and the scintillator for 
possible reasons for the slower discharge, it was attributed to electron charge in the cable 
discharging through the amplifier of the oscilloscope which is designed to perturb the 
circuit minimally, and to the possible reflection of the signal in the cable.   These were 
rectified using an external amplifier as a virtual ground. 
 
Observing the signals using an operational amplifier as a virtual ground 
An amplifier with an input impedance of 50 Ω was constructed in order to match the 
iterative impedance to the characteristic impedance (52 Ω) of the RG-58 cable used.   
 
 
 
 Fig. 2-5.  Design of the amplifier used to match the input and output impedance    
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         Fig. 2-6.  Set-up with the operational amplifier 
 
 
The output from the linear accelerator was observed for a 6MV beam delivered at 
different dose rates, using the operational amplifier mentioned above as a virtual ground 
for the co-axial cable.     
 
The following figures show the observed output signals from the linear accelerator with 
the addition of the cable terminating amplifier.     
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  Fig. 2-7.  Output of the linear accelerator for a 6MV beam at a dose rate of 600 MU/min. 
         
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-8.  Output of the linear accelerator for a 6MV beam at a dose rate of 100 MU/min. 
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As seen from figures 2-7 and 2-8, the stopping transient which is governed by the time 
constant of the cable and the resistance of the oscilloscope (1 MΩ) is longer than the 
starting transient by duration of the order of micro seconds.  The difference in the 
duration of the starting and stopping transients is not significant enough to need further 
rectification.  For the purpose of timing to start the decay activity, the signal can be 
considered to fall off sharply as it does on the rise.  The ringing on the fall-off side is a 
function of the amplifier and does not affect the signalling of the photon beam having 
been off.  The pulses are seen to be broader and closer spaced for higher dose rate and 
vice versa.   
 
 
2.1.3  Design of the radiation time monitor 
The radiation time monitor is designed to give a signal when the beam turns on and 
when it turns off.  This signal (standard TTL) is fed into the analyzer in order to start the 
analyzer to measure the decay activity.  The components of the radiation time monitor 
(and their signals) are shown below.   
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          Fig. 2-9.  Components of the radiation time monitor 
 
As seen in figures 2-7 and 2-8, the pulses from the linear accelerator are of the same 
height, regardless of the rate of irradiation.  It is the width of the pulse that varies 
according to the dose rate that was set.  The threshold for the comparator was set to a 
third of the voltage (pulse height) of the accelerator output.  The comparator first starts 
but then resets the monostable each time the output of the linear accelerator exceeds the 
set threshold.  When an output pulse is not followed by another pulse (i.e.) the output of 
the accelerator is below the set threshold for more than 50 milli seconds, the monostable 
is not reset and gives out a pulse which is used to signal enabling of the analyzer.   
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Fig. 2-10.  Design of the comparator (LM710B) shown in figure 2-9. 
 
              Fig. 2-11.  Design of the monostable (74123) and the cable driver (74125) shown in figure 2-9. 
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Figures 2-10 and 2-11 show the design of the comparator and of the montostable 
(standard components of an integrated circuit modified to fit the function of the radiation 
time monitor) which satisfies the condition of the radiation having gone off after having 
been turned on.  Figure 2-12 shows the set up of the radiation time monitor to start the 
analyzer immediately after the beam had been turned off following irradiation. 
 
                      
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2-12. Set up with the radiation time monitor. 
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2.2  The experiment 
Figure 2-13 shows the set up for analyzing the activation products from the irradiated 
sample.  A sodium iodide scintillator coupled with a photomultiplier was used to detect 
the activation products.  The multi channel analyzer would start analyzing the products 
detected by this scintillator when it receives the signal from the radiation time monitor.  
Thus, only the 511 KeV photons that result from the annihilation of positrons which are 
emitted by the proton-rich nuclei as a result of giant dipole resonance between Ca-40 in 
bone and photons of 15-23 MeV are analyzed by the analyzer. 
 
 
         
   Fig. 2-13. Set up for the proposed experiment 
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2.2.1  Calibrating the multi-channel analyzer 
The multi-channel analyzer was calibrated using three sources of known radioactivity, 
Na-22, Co-60, and  Th-232.  Peaks corresponding to energy of 511 and 1275 KeV from 
the Na-22 source, 1170 and 1330 KeV from the Co-60 source, and 300, 543, 873, 1620, 
and 2117 KeV from the Th-232 source were used to calibrate the multi-channel analyzer.   
The present activity and half-life, the energies and their emission probabilities of the 
isotopes used are shown in the table below.  The original activity of the Th-232 source 
was not known and hence, not included in the table.  The original activity of the other 
two calibration sources were known to an accuracy of approximately 2%.                  
 
Isotope used Activity (µCi) Half-life (day) Energy (KeV) Emission 
probability (%) 
       Na-22        0.00536               950           511 
         1275 
           178 
           100 
 
      Co-60          0.258          1925          1170 
         1330 
           100 
           100 
 
          Table 2.1  present activity, half-life, energy and emission probability of the isotopes used for 
calibration. 
 
 
The following graphs show the semi-log plots of number of counts detected vs. channel 
number of the analyzer.  The radioactive sources were counted for approximately 75 
minutes and normalized for 75 minutes in order to obtain good statistics in the peak 
evaluations.   
 
 38 
 
 
                         
 
         
 
 
 
 
 
          Fig. 2-14. Decay of Sodium – 22. 
 
 
 
 
        
  
 
 
 
    
  
    
  
    Fig. 2-15.  Decay of Cobalt – 60.            
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   Fig. 2-16.  Decay of Thorium – 232. 
 
 
 
 
Peak extraction was done assuming the peaks to be Gaussian, the energy deposition by 
the photons in the scintillator being statistical.    The standard deviation in the energy 
measured from the spectra is shown as the vertical error bars in the calibration graph 
shown in figure 2-17 below. 
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  Fig. 2-17.  Calibration graph for the multi channel analyzer. 
 
 
 
The response of the multi channel analyzer was found to be linear in the range of energy 
shown in figure 2-17.  It can also be seen that when 1024 channels are used for the 
analysis, the peak of 511 KeV is expected to be at channel #129 of the analyzer.  The 
zero level of the analyzer has an instability of less than or equal to + 0.01% for a 24 hour 
period at constant temperature and line voltage.  Given this electronic wander of the zero 
level along with the 1% integral linearity of the analyzer, the peak for 511 KeV can be 
expected to be at channel #129 + 10 channels. 
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When the analyzer is used in quarters (256 channels each) for the energy decay analysis, 
the peaks of 511 KeV can be expected at channels 32, 288, 544 and 800 + 3 channels. 
 
 
2.2.2  The detector 
The thallium doped sodium iodide [NaI(Tl)] scintillator used is 3 inches (76 mm) in 
diameter and 4 inches (102 mm) long.  It was coupled with a photomultiplier whose 
power system was modified so that the photocathode was at ground potential rather than 
being at a negative potential (-1300 volts) in order to make the electric field uniform at 
the photocathode.   
 
   
 
 
 
         
     
(a)                                                                        (b)                                                                            
 Fig. 2-18.  (a) original - photocathode at a negative high potential.  (b) modified – photocathode at ground 
potential. 
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As shown in figure 2-18, the original negative potential for the photocathode was 
modified to be at zero and in order to be able to see the output of the photomultiplier 
onto an oscilloscope, a coupling capacitor was added to the detector chain. 
 
Measured detector parameters 
The detector had an intrinsic efficiency (gross detection efficiency) of 20% which is 
typical for a crystal of the size used.  This was determined using the background 
subtracted Co-60 spectrum.  
  
The following table shows the peak to Compton ratio for an uncollimated isotropic 
radiation source obtained with the detector with the photon energies employed for 
calibrating the multi channel analyzer when set to pulse height analysis. 
 
      Energy                             Peak to Compton ratio  
  
     2.5 MeV                      1.1 
     1.2 MeV                      1.8 
    0.7 MeV                      2.5 
    
     Table 2.2  Peak to Compton ratio obtained with the NaI detector.   
 
Detecting photons of energy 511 KeV from the activated sample and measuring the rate 
of decay of the 511 KeV photons is a significant part of the experiment.  The detector 
having a high peak to Compton ratio at an energy closer to 511 KeV (700 KeV, in the 
table) is helpful for the experiment.     
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The activation products from the experimental sample will not be collimated in order to 
avoid detecting activation products from the collimator and also in order to detect as 
many photons from the activated sample as possible. 
 
For an uncollimated source that emits isotropically, the detector had a relative resolution 
of 10.1% at 511 KeV, the photon energy of interest.  Relative resolution was determined 
using the full width at half maximum of the photo peaks in the spectra used for 
calibration.  The following table summarizes the relative resolution and the resolution 
efficiency of the detector found using the two calibration sources at the expected 
working distance.   
 
     Energy                    Relative Resolution        Detection efficiency 
  
    511 KeV               10.1 %                                 16.6 % 
   1170 KeV 
   1275 KeV  
               6.2 %                                   4.9 % 
               6.1 %                                   5.3 % 
   1330 KeV                5.4 %                                  3.6 % 
 
        Table 2.3  Relative resolution and resolution efficiency of the detector 
 
As can be seen from table 2.3, the detector has a higher detection efficiency (full-energy 
or photo peak efficiency) at 511 KeV compared to that at higher energies.  The photo 
electric interaction is the predominant interaction process at lower photon energies, with 
more of the incoming photon energy being deposited in the full energy peak compared to 
the higher energy photons that are Compton scattered. 
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2.2.3 Calibrating the detector 
 
 
 
 
 
  
          
 
 
 
          Fig. 2-19  Set up for calibrating the detector 
 
A device was made to hold the irradiated sample in front of the detector at 6.25 cm.  It 
was made of polystyrene, avoiding metal screws.  It had openings on the sides that the 
bone could be quickly and easily inserted through, so it held the bone in front of the 
detector without anything in between the bone and the detector.  The detector was 
calibrated with a radioactive Na-22 source of known activity placed at different points on 
the holder in order to know what fraction of the radiation emitted from the activated 
sample is detected.   
 At the center (marked 0 cm), the detector of radius 3.8 cm has its edges at a 
distance of 7.3 cm from the center of the bone holder, subtends a solid angle of 0.9 
steradians and is expected to count roughly 7% of the radiation (511 KeV photons) 
emitted by the isotropic source, and was found to detect 10.5% of the emitted 511 KeV 
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photons.  At 5 cm on either sides of the center, the detector was able to count 10-12% of 
the radiation emitted by the source.  At 7.5 cm on either sides, the detector counted 8% 
of the emitted 511 KeV photons. 
 
2.2.4 Sample to be irradiated 
An experiment sample was made of calcium carbonate (CaCO3) contained in a thin 
plastic vial that was available.  Plastic was chosen because of its low atomic number.  As 
the components of the plastic vial was not known, the empty vial was irradiated and 
made sure that it showed no activation.  Calcium carbonate was chosen since it contains 
more calcium per unit volume compared to that of a real bone.  More calcium in the 
sample is desired in order to see a higher yield of positrons from the giant dipole 
resonance of Ca-40 with the photons of the appropriate energy.  The sample consisted of 
25.5 grams of calcium carbonate, placed in a cylindrical container measuring 15 cm in 
length and having a radius of 1 cm.  After testing the experimental procedure using this 
sample, the experiment was done in a real bone also in order to estimate dose 
enhancement in bone due to giant dipole resonance of calcium in bone with the 
resonance energy photons in the beam. 
 
2.2.5  The various trials   
As shown in figure 2-13, the detector is in the treatment room in order to detect the 
activation products from the irradiated sample.  The recovery time of the detector is in 
the order of micro seconds (0.23 micro seconds for the NaI crystal, along with a recovery 
time of a few micro seconds for the associated electronics).  Because of this short 
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recovery time, the scintillator being saturated with events during the time that the beam 
is turned on was not thought to be of concern.  The activation products in the room 
following an irradiation at the 25 MV setting have a maximum energy of about 2 MeV
30
.  
In order to make this background smaller, for the scintillator to not be saturated 
immediately following the irradiation, the detector was shielded in an enclosure made of 
lead bricks which provided shielding thickness of up to 20 cm.    
 Various positions and configurations of the detector and the enclosure were tried 
in order to be able to detect the signal from the activation products of the sample above 
the signal from background in the room following the irradiation.  The collimator jaws 
and the flattening filter in the linear accelerator head and the treatment couch being also 
sources of neutrons
31
 as a result of photo nuclear reactions that follow a high energy 
irradiation, various gantry positions were tried along with the different configurations of 
the detector and its shielding enclosure.  Trials were also done with the detector set up in 
the maze where the irradiated sample can be pneumatically transported to.  The 
scintillator was found to be saturated by the induced back ground activity in the room in 
all of the above-mentioned trials due to products of the photonuclear and neutron capture 
reactions that are consequences of a high energy irradiation.  Neutron shielding was not 
used as the saturation was due to induced back ground activity and also because NaI as a 
crystal detector, does not have a high sensitivity to neutrons.    
 Having done differential trials to rule out the possibility of the leakage current in 
the capacitor due to radiation damage and activation in the components of the detector or 
in the lead blocks used for shielding the detector, the scintillator being saturated was 
attributed to high induced activity in the room (from the gantry components and from the 
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construction materials of the walls) immediately after a 25 MV beam had been turned off.  
This induced activity produced a signal that was too high to be able to detect the signal 
from the activation products of the sample.  This was further confirmed by the fact that 
the scintillator was found to be not saturated following an irradiation done at a peak 
voltage of 6 MV.  Since the photon energy of the resonance needs energies between 15 
and 25 MeV, the irradiation needs to be done with the linear accelerator operating at a 
peak voltage of 25 MV in order to induce the resonance.  The original procedure was 
therefore modified so that the experiment can be done using a radiation beam obtained at 
a peak voltage of 25 MV and to be able to detect signals from the activated sample above 
the signal due to activation in the room, the highest source of activation being the 
components (collimators, filters, etc.) of the accelerator itself and the construction 
materials of the walls of the room. 
   
2.3 The Modified procedure    
 
 
 
 
 
 
 
 
            Fig. 2-20  Set-up for the modified procedure   
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As shown in figure 2-21, the detector and the associated electronics were kept outside 
the treatment room, in order to avoid the high induced background activity in the room 
due to the high flux of neutrons following an irradiation at the 25 MV setting.   The 
sample, following the irradiation would ideally be pneumatically transported to the 
detector in order for the activation products to be counted.  However, because of the 
unavailability of pneumatic transport, the irradiated sample will be manually carried over 
to the detector, following safe practices of distance and time, with the transit time being 
recorded.  The detector being outside the treatment room and the sample being brought 
out to the detector after the termination of the irradiation makes the use of time pick-off 
unit and the radiation time monitor unnecessary.  Bringing the irradiated sample out to 
count also meant that the only activated radioactivity in the vicinity of the detector is the 
activation from the sample. 
 Therefore, this procedure was carried out with the detector outside the treatment 
room.  When the irradiated sample of calcium carbonate was brought out to the detector 
to be analyzed, a 511 KeV peak was observed against the general background.  The 
decay of this peak was observed at different times in the different quarters of the 
analyzer memory, the analysis of which is shown in the next chapter.  When this 
procedure was repeated with the analyzer working in the time mode, the decay of 
activity was observed against time.  An analysis of the decay of counts of the activation 
products against time will help identify the nuclear series that is decaying by positron 
emission following a photo disintegration process.     
  
 49 
 
 
 
2.3.1  Trial 1 
The detector chain was set up as shown in figure 2-21.  The multi channel analyzer, in its 
energy mode, was set to count for 20 seconds each in four quarters.  The linear 
accelerator (Varian 2300 cd) was set to deliver a beam at a peak voltage of 25 MV, at a 
dose rate of 600 monitor units per minute.  The vial of calcium carbonate was set at 100 
cm source to surface distance and irradiated with a field size of 3 x 15 cm for 20 seconds.  
The irradiated and activated sample was manually brought out from the treatment room, 
following procedures as stated, and placed in the holder in front of the detector.  The 
decay of the induced activity in calcium carbonate was observed with the analyzer 
working in its energy mode in order to detect the 511 KeV photons.  The same procedure 
was then repeated with an avian (flightless) bone irradiated at the same setting.  Avian 
bone was chosen because of the availability of fresh and uncut bone.  As birds of flight 
tend to have more hollow bones than that of flightless birds, flightless avian bone was 
chosen.   
Using the same set-up parameters and irradiation conditions, the bone was irradiated the 
next day and the decay of the induced activity was recorded with the analyzer working in 
its time mode.  In addition, to measure the increase in dose due to the decay of activation 
products, thermoluminescent dosimeters (TLD) of lithium fluoride of 1 mm x 1 mm x 
1mm were used to measure dose in tissue surrounding bone and in boneless tissue.  The 
TLDs were known to have a sensitivity 10 pGy to 10 Gy.  
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2.3.2  Trial 2 
A second trial was performed using a beam at a peak voltage of 18 MV and a dose rate 
of 600 monitor units per minute.  200 monitor units were delivered to the vial of 99.99% 
pure calcium set at 100 cm source to surface distance.  The decay of the irradiated and 
activated sample was measured with the analyzer working in the time mode.  Using the 
same beam parameters, 0.034 Kg of bone, 0.346 Kg of tissue, and 0.456 Kg of bone 
surrounded by tissue were irradiated.   
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Chapter 3 
 
Analysis and Results 
 
 
3.1  Analysis of data 
    
 
 
 
 
 
 
 
 
 
  
  
   
   Fig. 3-1.  Background activity measured against time. 
 
 
Figure 3-1 shows the background activity that was measured before the start of the 
experiment.  The background was found to be steady.   
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 Fig. 3-2.  Measured activity from the sample of bone after being irradiated by a 6MV beam. 
 
  
 
Figure 3-2 shows the activity that was measured from the sample of bone that was 
irradiated with a 6MV beam.  The sample showed no activation, as expected, as it 
requires a photon energy of 8 MeV or more for activation in the sample, given that 
neutron binding energy in most nuclei is approximately 8 MeV.   
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      Fig. 3-3.  Decay of 511 KeV photons with time, as measured from the activated sample of CaCO3. 
 
 
Figure 3-3 shows the decay of 511 KeV photons from the activated sample of calcium 
carbonate, with error bars showing random error (square root of counts) in the measured 
counts.  The vial containing the sample was irradiated using a 25MV beam.  The residual 
activity was counted for nearly two and half minutes with the multi-channel analyzer set 
to detect and count 511 KeV photons.  The decay of 511 KeV photons with time, on a 
semi-log plot, gives a half-life of 124 + 0.1 seconds.  The uncertainty in the measured 
value of half-life arises from variations in human reaction times, as estimated by 
repeated simulated measurements of different time intervals of the decay being counted 
in the different quarters of the multi channel analyzer.   
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The measured half-life of 2.07 + 0.002 minutes corresponds to the decay of 
15
O from the 
16
O (γ,n) 15O reaction with a half-life of 2.05 minutes.6 
 
    
 
 
 
 
 
 
  
 
 
 
 
Fig. 3-4.  Decay of 511 KeV photons with time as measured from an activated sample of bone.  
 
 
The above figure shows the decay of 511 KeV photons from a sample of bone activated 
using a 25 MV beam of photons.  As with the sample of calcium carbonate, the residual 
activity was counted for about 150 seconds with the multi-channel analyzer set to detect 
and count 511 KeV photons, the error bars showing random error (square root of counts) 
in the measured counts. 
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The decay of 511 KeV photons with time, on a semi-log plot, gives a half-life of  
122 + 0.1 seconds, the uncertainty in the measurement of which is as discussed in the 
previous page.  This measured half-life of 2.03 + 0.002 minutes, again, shows the decay 
of 
15
O which has a half-life of 2.05 minutes, from the 
16
O (γ,n) 15O reaction. 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
Fig. 3-5.  Exponential decay of activity from a sample of bone irradiated by 25 MV beam, with the 
inset showing error bars (random error in the counts) for a few typical points. 
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 Fig. 3-6.  Decay of activity from the sample of bone irradiated with 25 MV beam of photons, with the 
inset showing error bars (random error in the counts) for a few typical data points. 
 
Figures 3-5 and 3-6 show the background subtracted decay of activity with time from a 
sample of bone irradiated with a 25 MV beam of photons, on a linear and semi-log scale 
respectively.  The exponential (y = 1425.6e
-0.0048x
 + 209) and linear graphs (y = -0.0048x 
+ 7.21) give a decay constant of 0.0048 per second, which corresponds to a half-life of 
2.4 minutes.   
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The half-life measured by decay of activity (in the time mode of the analyzer) differs 
from that measured by the decay of 511 KeV photons (in the energy mode of the 
analyzer) by about 16%.  The decay of 511 KeV photons was counted with the analyzer 
in the energy mode for about 150 seconds (figures 3-3 and 3-4) while the decay of 
activity was counted with the analyzer in the time mode for roughly 500 seconds (figures 
3-5 and 3-6).  The counting time for the energy mode was too short for the measured 
half-life to be influenced by any competing decay of half-life longer than the measured 
122 seconds.  The counting time for the time mode was long enough for a competing 
decay of longer half-life to influence the measured half-life.   
 
The presence of 
12
C in the samples irradiated accounts for the competing decay of 
11
C 
from the 
12
C (γ ,n) 11C reaction.  11C decays with a half-life of 20.1 minutes13, the 
influence of which can be seen as an increase in the measured half-life from the sample 
that was counted for about 8 minutes, compared to that which was measured from the 
sample that was counted for about 2.5 minutes.  In experiments done to study tumor 
blood flow by measuring positron activity, it had been found that beyond ten minutes 
post activation, 
11
C becomes the major source of activity from the activated sample.
38 
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 Fig. 3-7.  Decay of activity from a sample of bone irradiated by an 18 MV beam of photons.  The  
 inset shows a few typical points with error bars  (random error in the counts). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
 
            
          Fig. 3-8.  Decay of activity from a sample of tissue irradiated by an 18 MV photon beam.  The 
          inset shows error bars (random error) for a few typical points.   
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Figures 3-7 and 3-8 show the decay of activity measured from a sample of bone and a 
sample of tissue respectively, irradiated by an 18 MV beam of photons for roughly 19 
minutes. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3-9.  Decay of activity as seen from a bone surrounded by tissue after being irradiated with 18 MV 
photons.  Error bars showing the random in the number of counts are not visible in the scale of the Y-axis. 
 
 
Figure 3-9 shows the decay of activity measured from a sample of bone surrounded by 
tissue irradiated by an 18 MV beam of photons for about 19 minutes. 
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The decays shown in the figures 3-8 (y = 6759.9e
-0.005x
) and 3-9 (y = 14295e
-0.005x
) yield 
a half-life of 2.3 minutes.  This half-life is comparable to what was measured using a 
sample of bone activated by 25 MV photons, as shown in figure 3-5.  This is also 16% 
higher than the half-life measured from figures 3-3 and 4 due to the decay of 
11
C with a 
longer (20.1 minutes) half-life.   
Figure 3-7 (y = 2409.4e
-0.0043x
) yields a higher half-life of 2.7 minutes.  The sample of 
bone had to be adjusted in the holder during the counting.  The trial was not repeated as 
the sample was already activated. 
 
3.2  Result 
As seen above, the measured half-lives correspond to the decay of 
15
O resulting from the 
 
16
O (γ,n) 15O reaction.   
 
The following figure (3-10) shows the measured activity of 99.99% pure calcium 
irradiated by 18 MV photons.  No decay of significance was observed due to the delay in 
starting the analysis of decay of 511 KeV photons.  As discussed in sections 2.2.5 and 
2.3, the irradiated sample had to be manually transported for the decay products to be 
analyzed.  The transit time of minimum 20 seconds meant not being able to observe the 
decay of the shorter half-life of 0.9 seconds for calcium.     
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Fig. 3-10.  Measured activity from a sample of 99.99% calcium after being irradiated by an 18 MV beam. 
 
 
 
The duration of the counting time was not long enough to measure the decay rate of 
11
C, 
as the counts from the sample were not distinguishable from those of the background 
past eight or nine minutes.
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Chapter 4 
Discussion 
 
   
4.1  Energy of the incident photons 
 The spectrum of a megavoltage photon beam is that of bremsstrahlung emission 
produced by thick targets and filtered by flattening filters and shaped by collimators.  
The maximum photon energy is equal to the maximum incident electron energy.  The 
photon fluence increases with decreasing energy typically reaching a peak at an energy 
about one-third of the maximum.  At energies lower than at the peak, fluence decreases 
due to the attenuation of low energy photons by the target material.
39
 
  
Direct measurement of photon energy distribution of the bremsstrahlung spectrum is not 
feasible due to the high fluence of the high energy photon beams saturating the detectors 
and the challenge of determining detector efficiency for high-energy photons.  Photon 
fluence information in clinically used photon beams is helpful for accurate dose 
calculations especially around tissue interfaces and inhomogenity, for accurate 
modelling  
of energy response of various detectors, and also for better design of treatment head and 
flattening filter.
40
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In the kilo voltage energy range, the total attenuation coefficient is steeply decreasing 
due to the dominance of photoelectric interaction (refer figure 1-4) which allows for a 
good differentiation between successive energy intervals.  However, in the megavoltage 
energy  
range, the slowly decreasing Compton cross section and the increasing contribution of 
pair production cross section to the total attenuation coefficient leads to reduction in 
energy differentiation, making the task of deriving the spectra more demanding on the 
method employed.
41
  Various methods that estimate the energy distribution include 
estimating the spectrum by matching measured depth-dose,
42
 attenuation or transmission 
analysis,
42,43
 Laplace transform,
44
 Monte Carlo simulation, etc.   
  
Currently, Monte Carlo simulation remains the most comprehensive and potentially 
more accurate method to estimate the energy distribution of photons in a clinical 
beam.
45,46
  The accuracy of Monte Carlo simulation is limited to the modelling of the 
treatment head and assumptions made concerning the electron beam incident on the 
target.
41
  The information on the design of the treatment head is difficult to obtain from 
competing manufacturers.  Also, with constantly improving accelerator designs, even 
within a given model, machines are often adjusted for individual purchasers to match 
previous beam characteristics.
47
   
 
The photon fluence information available from the Monte Carlo simulation using BEAM 
code
45,46
 has been used for the purposes of calculating interaction probabilities for the 
activation of the observed reaction. 
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4.2  Interaction cross-section for the observed reaction 
The threshold for this interaction, as seen from figures 1-6 and 1-7 for the O
16(γ,n)O15 
reaction is 15.5 MeV.  The reaction has resonances at various higher energies with a 
maximum cross section of 15 milli barns around 22 MeV.  At the energy of the photons 
that are available in the bremsstrahlung beam to initiate the reaction, the reaction had a 
cross-section of 1.25 x 10
-29
 cm
2
 / atom. 
 
The neutrons released in this reaction are high-ranged particles and deposit dose outside 
of the sample.  The positrons, being charged particles deposit dose along their track, 
before annihilating with an electron to produce two photons of 511 KeV each.   
 
 
4.3  Dose due to the positrons released 
The deposition of energy by moving charged particles is mainly a result of a series of 
electric field interactions that occur at random along its track.  The particle's energy loss 
–dE, along a portion of its track dx, is dependent on its velocity v, charge Z, and the 
electron density of the target .48 
-dE/dx  Z2 / v2 
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4.3.1  The range of the positrons 
 Electrons and positrons follow a tortuous path in matter due to elastic and 
inelastic scattering by atomic nuclei and electrons.  In the energy range of 10
4
 eV to  
10
7
  eV, the difference between energy loss and multiple scattering of positrons and 
electrons is insignificant.
49 
 
In this energy range, their deflection in matter is due almost entirely to the elastic 
collisions with atomic nuclei
49
, with an interaction probability that is proportional to the 
square of atomic number of the medium (Z
2
) approximately to 1/E
2
 where E is the 
kinetic energy of the incident positrons.  The scatter angle is inversely proportional to the 
energy of the positrons.  Energy loss due to Bremsstrahlung in the Coulomb field of the 
nucleus is negligible. 
 
Their energy loss is primarily from inelastic interactions with atomic electrons, where 
the incident electron loses energy and gets deflected at some angle with respect to the 
original.  This interaction probability increases with the atomic number of the medium 
and decreases rapidly with increasing kinetic energy of the incident positrons.
50
  The 
energy transferred to the atoms per collision is very small. The total energy loss after 
passage through a given thickness of matter is therefore the result of a very large number 
of small energy losses.
49
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The range of the positrons is defined as the penetration depth (a straight line path) which 
can be identified by statistical distribution parameters like full width at half-maximum 
(FWHM).
51
  The average energy lost per distance (dE/dx) traversed by an ionizing  
particle in a material made of independent atoms and due only to inelastic processes 
(ionization and excitation) has been given by the Bethe–Bloch formula*. 
 
The value for dE/dx rapidly increases as the positron slows down and therefore most of 
the ionization created in an electron track will be towards the end.   
Thus, at the beginning of the track (at higher energies), scatter at small angles is 
dominant.  As the positron slows down toward the end of its trajectory, scattering at 
large angles becomes more frequent, and energy loss, dE/dx increases rapidly.
49
  
Therefore most of the ionization created in an electron/positron track will be towards the 
end. 
 
Therefore, it is pertinent to use pathlength, l obtained by using the continuous slowing 
down approximation range, given by the integral of the reciprocal of the stopping power 
 
_______________________________________________________________________ 
*  dE/dx = 4 ro
2
 (mc
2
/β2) N Z (A + B) 
   where A = ln [ βγ √(γ-1) mc2 / I ] 
 B = 1 / (2γ2) { [(γ-1)2 / 8] +1 – (2γ2 + 2γ – 1) ln2 } 
 γ = 1/√(1-β) 
 N is the number density of atoms in the medium 
 ro is the classical electron radius, and 
 I (eV) is the average excitation potential of the medium. 
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of the medium (until the velocity of the particle falls to a value comparable to that of 
atomic electrons) for dose considerations. 
l(T) =   
 

 
  
  
  
  
 
  
dT 
where 1/ (dE/dx) is the stopping power of the medium and  
 T is the kinetic energy of the positrons. 
 
Experiments
52,53
 have shown the average range of the positrons to be 8 mm and 5 mm in 
muscle (soft tissue and body fluids) and in bone respectively for a maximum energy of 
1.7 MeV.  For an average energy of 0.7 MeV, the average range has been measured to be 
2.8 mm in muscle and 1.7 mm in bone.   
Given the short range of positrons, it can be assumed that the energy absorbed by the 
medium is equal to the energy released in it by the positrons.  
 
4.4.2  Linear Energy Transfer of the positrons 
Linear energy transfer (LET) is the average energy lost by the particle over a given path 
length.  It depends on the velocity and hence, the energy and the charge of the particle.
54
  
When the charged particle has its full energy, LET is small.  As the particle loses energy 
more rapidly toward the end of its range, it reaches a maximum rate of energy loss, also 
known as the Bragg peak, just before it comes to rest.  The LET of the particle, therefore, 
varies along the length of its range. 
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Due to the multiple deflections that it goes through as it slows down, the Bragg peak (a 
sharp and significant increase in the energy deposited at the end of the track) is not 
observed for positrons.
54
  The positron has an increased energy loss, dE/dx at its 
termination, and a range of LET values along its path.  But, since the initiation 
(following an irradiation with photons) and termination of the positron tracks occur at 
random in the tissue, the LET spectrum is similar at all depths.
55 
 
 
The end-point energy of 1.7 MeV of the positrons corresponds to a linear energy transfer 
of 0.188 KeV/μm in muscle and 0.174 KeV/μm in bone.  The LET of positrons with an 
average energy of 0.7 MeV is 0.193 KeV/μm in muscle and 0.1799 KeV/μm in bone.56 
 
4.3.3  Measured local dose enhancement due to positrons 
As mentioned in section 2.2.3, the detector was calibrated with a radioactive source of 
Na-22 of known activity at various positions along the length of the bone holder.  
Averaged over the length of the bone, the detector was found to detect 10% of the 
radiation emitted.  The positron emission following the (γ,n) reaction is delayed (not 
prompt).  As the direction of positron emission from the vibrating nucleus is not 
correlated to the direction of the photon's incidence, the positrons are emitted 
isotropically.  The duration of the photon flux was also of short enough duration 
compared to that of the measured half-life. 
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Assuming the positrons to deposit dose in a sphere of radius equal to their range (with 
the spheres overlapping), the dose deposited per positron in bone was found to be 1.97 x 
10
-9
 Gray*.  With the number of positrons as estimated by the counts of 511 KeV 
photons detected, the dose deposited by the positrons in bone was found to be 0.18 milli 
Gray for an externally delivered dose of 13 Gray.  (Refer to Appendix 1) 
 
Similarly, the dose deposited per positron in tissue was found to be 1.22 x 10
-9
 Gray.  
With the estimated total number of positrons emitted, the dose deposited by the positrons 
in the sample of tissue was found to be 0.025 mGy for an externally delivered dose of 13 
Gray.  (Refer to Appendix 2). 
 
The bone was assumed to be a cylinder of radius 0.6 cm.  The attenuation of 511 KeV 
photons by the sample has been considered to be negligible in this calculation. 
The dose enhancement in the sample of bone was found to be about seven times higher 
than that in the sample of tissue.    
The ratio of oxygen to other elements in bone is higher than that of tissue.  A form of 
apatite with most of the OH groups being replaced by many carbonate and phosphate 
substitutions is a large component (up to 70% by weight) of bone material**.   
 
_______________________________________________________________________ 
* 1 Gray = 1 Joule/Kilogram 
** Ca5(PO4)3(F,Cl,OH) 
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This measured enhancement of dose is due to positrons from the decay of the 
15
O which 
was a product of the 
16
O (γ,n)15O reaction.  This measurement does not include the dose 
delivered locally by positrons emitted promptly due to pair production while the beam 
was on. 
 
4.4  Thermoluminescent dosimeters  
Thermoluminescent dosimeters (TLD) give a measure of absorbed dose at the site of 
insertion.  They measure dose due to both primary and secondary charged particles.  The 
results of this measurement are not sufficient to measure the dose delivered by positrons 
alone in tissue and in bone.   
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Chapter 5 
 
Conclusion 
 
 
5.1  Measured dose enhancement 
 To the accuracy of the calculations, the measured dose enhancement from the recoil 
energy of positrons in bone was 0.002% of the externally delivered dose.  In tissue, it 
was measured to be 0.00031% of the dose delivered externally.  This measurement was 
from the spectrum obtained from the activated samples.  Thermoluminescent dosimeters 
and photochromic films are not sensitive enough to measure this enhancement over the 
externally delivered dose. 
 
5.1.1  Expected positron yield 
From figure 1-6, the reaction has a cross section of 1.25 x 10
-29
 cm
2
/atom at the range of 
photon energies that was available in the bremsstrahlung beam.  Using the simulation 
information from reference 45, about 1.3% of the incident photon beam was of the 
energy that could initiate the 
16
O (γ,n)15O reaction.   
 
Assuming the bone to be a cylinder, using the average volumes of the circumscribed and 
inscribed cuboids, the number of oxygen atoms in the sample was estimated.  As the 
sample was not of crystalline form where the atoms are arranged in lines, and also due to 
the small thickness of the sample, it can be assumed that there was no hiding of the  
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atoms.  As the cross-section was of the order of 10
-29
 cm
2
, it can be assumed that the 
absorption of photons was the same in every layer of atoms.   The expected yield of 
positrons from (γ,n) reaction was estimated to be of the order of 105 to 106 in magnitude.  
(Appendix 3).  The measurement using the spectrum of activated samples yielded 
positrons of order of 10
5
 in bone, as shown in appendix 1. 
 
The interaction cross-section for the reaction and number of photons available in the 
incident beam of energy needed to initiate the reaction are small.  The highest measured 
cross section for the reaction is 15 milli barn at 22 MeV.  Enhancing the reaction offers 
the possibility of introducing excited oxygen atoms and hence secondary charged 
particles (positrons) into the irradiated region, in addition to the primary electrons and 
positrons released due to the interaction of the incident photons with the irradiated matter. 
 
 
5.2  Enhancing the reaction in a high energy linear accelerator  
As the photo-activation of 
15
O is most effective at energies between 20 and 30 MeV
57
, 
the 
16
O (γ,n)15O reaction can be enhanced by choosing the energy of the incident photons 
appropriately. 
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5.2.1 Filter to absorb lower end of Bremsstrahlung 
The 
16O (γ,n)15O reaction has a threshold energy of 15.5 MeV.  As mentioned in section 
2.1.1, the lower energy photons (in the Bremsstrahlung spectrum and Compton scattered 
photons) do not contribute toward activating the desired reaction, but toward the 
externally delivered photon dose and hence not to the dose enhancement.  The apparent 
probability of the reaction for a given total flux of photons can be enhanced by removing 
the lower energy photons from the beam incident on the sample.     
 
Experiments done for studying perfusion imaging using in situ 
16O (γ,n)15O activation 
have used a 12 cm thick carbon block to preferentially absorb the lower energy photons 
in the beam in order to achieve this desired result.
58 
 
  
 
  
 
 
 
 
 
 
 
      
Fig. 5-1.  Total photon attenuation cross-section in Carbon as a function of photon energy
58
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As seen from figure 5-1, low atomic number materials like carbon have a higher cross 
section at lower photon energies compared to that at higher energy.  Carbon has a cross-
section of 1.3 barns/atom at MeV and 0.31 barns/atom at 20 MeV.  The high cross-
section at lower energy and the decreasing cross-section with increasing energy (within 
the energy range of 1 MeV to 30 MeV) is conducive to absorbing lower energy photons 
from the Bremsstrahlung spectrum.   
  
5.2.2  Neutron contamination in a high energy linear accelerator 
When the incident photon beam contains photons of energy 8 MeV or higher, (γ,n) and 
(e,n) reactions are initiated.  The photo-neutrons are generated mainly when the photons 
interact with the high atomic number materials in the components (bremsstrahlung 
target, filters, jaws, etc.) of accelerator itself
59
.  The neutrons react with elements in the 
patient, floor, ceiling and walls of the room and are of higher radio biological 
effectiveness than that of photons.  It has been found that neutrons in a typical treatment 
room are of energy ranging from 0.1 MeV to 10 MeV coming from the accelerator head, 
and of energy less than 0.1 MeV when they are scattered.
60
  Neutrons of energy 2.5 MeV 
have a LET (linear energy transfer) of 15-80 KeV/μm and that of energy 14 MeV have a 
LET of 3-30 KeV/μm.61  Monitoring neutron production and neutron shielding becomes 
a necessity when the accelerator is being operated at high (10 or above) mega voltages. 
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5.3  Enhancing the reaction by using quasi monoenergetic beams  
The dose enhancing reaction can be maximized by choosing the energy of the incoming 
photons to be within 20 and 30 MeV.  Quasi monoenergetic photon beams are an 
attractive option as the reaction has high cross-sections at certain energies, as seen from 
figure 1-6.  Photons from radioactive sources and charged particle reactions are of 
discrete energy but are usually of low intensity and also are not of variable energy.   
 
5.3.1  Annihilation in flight of monoenergetic fast positrons 
Positrons of thermal energy produce two 511 KeV photons as they annihilate with an 
electron.  If the positron annihilates while in flight, its kinetic energy is imparted to the 
annihilation photons.  By choosing the velocity of the positrons appropriately, the 
annihilation photons can be of the desired energy within a small range. 
The positrons produced by pair production from an electron linear accelerator are 
magnetically selected for velocity to give a beam of nearly monoenergetic positrons.  
These positrons, when made to strike a low atomic number target annihilate in flight.  As 
momentum is conserved at small angles, it is possible to produce a beam of nearly 
monochromatic photons in the forward direction.  By varying the energy of the 
positrons, this photon beam can be made variable in energy.  Photon energy resolution of 
about 3% has been achieved using this method.
62
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5.4  Conclusion 
The dose delivered by secondary charged particles from the photo nuclear disintegrations 
that occur in the range of energies available in bremsstrahlung spectrum of photons was 
attempted to measure to explore the feasibility of local dose enhancement due to photo 
nuclear disintegrations. 
 
The predominant photo nuclear interaction that was measured in the range of photon 
energies available in the bremsstrahlung spectrum seems to be the 
16O (γ,n)15O reaction.  
The giant dipole resonance of calcium in bone could not be measured against the heavy 
background due to its short half-life.   
   
The measured dose enhancement in bone and in tissue due to the 
16O (γ,n)15O reaction 
was a small percentage of the externally delivered dose.  The dose enhancement due the 
photo nuclear reactions can be exploited to be of clinical significance by selectively 
choosing the energy of the incident beam to be predominantly of 20 – 30 MeV.   
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Appendix 1 
 
Average range of a positron of recoil energy 0.7 MeV in bone = 1.7mm 
Volume of a sphere of bone, of radius 1.7 mm = 2.058 x 10
-8
 m
3
 
Therefore, on an average, energy of 0.7 MeV is deposited within this sphere of bone.   
(i.e) 1.12 x 10
-13
 Joules of energy is deposited per positron within this sphere of bone. 
 
Taking the density of bone to be 1900 Kg/m
3
,  
mass of the sphere of bone under consideration = 3.9 x 10
-5
 Kg. 
Dose delivered to this mass = 2.87 x 10
-9
 Gray/positron. 
The decay equation of figure 3-4 (shown below) gives an estimate of 511 KeV photons 
detected from the positron decay.  Each positron decay resulted in the emission of two 
511 KeV photons.  The detector detected 10% of what was emitted into 4π steradians.     
The estimated number of positrons released after the irradiation = 91,440 + 675.    
Total dose delivered in the sample of bone by the recoil energy of positrons released in it 
= 0.26 + 0.0013 mGy. 
 
 
 
 
 
 
 
 
 
 
 
 Fig. 3-4.  Decay of 511 KeV photons with time as measured from an activated sample of bone.  
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Appendix 2 
 
Average range of a positron of recoil energy 0.7 MeV in tissue = 2.8mm 
Volume of a sphere of tissue, of radius 2.8 mm = 9.195 x 10
-8
 m
3
 
Therefore, on an average, energy of 0.7 MeV is deposited within this sphere of bone.   
(i.e) 1.12 x 10
-13
 Joules of energy is deposited per positron within this sphere of tissue. 
 
Taking the density of tissue to be 1000 Kg/m
3
,  
mass of the sphere of tissue under consideration = 9.195 x 10
-5
 Kg. 
Dose delivered to this mass = 1.22 x 10
-9
 Gray/positron. 
The decay equation of figure 3-8 (y = 6759.9 e
-0.005x
) gives an estimate of 511 KeV 
photons detected from the positron decay.  Each positron decay resulted in the emission 
of two 511 KeV photons.  The detector detected 10% of what was emitted into 4π 
steradians.     
The estimated number of positrons released after the irradiation = 33,800 + 411 .    
Total dose delivered in the sample of tissue by the recoil energy of positrons released in 
it = 0.04 + 0.0005 mGy. 
 
 
 
 
 
 
 
 
 
  
  
 
 Fig. 3-8.  Decay of activity from a sample of tissue irradiated by an 18 MV photon beam. 
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Appendix 3 
Order of magnitude calculation for the expected yield of positrons: 
 
The bone was modelled as a cylinder of radius 0.6 cm and of length 15 cm.  Taking the 
density of bone to be 1900 Kg/m
3
 and the density of marrow to be half the density of 
bone, the estimated number of oxygen atoms in this volume is of the order of 10
22
.   
Using geometrical considerations, this volume can be reasonably approximated as the 
average of the volumes of the circumscribed and inscribed cuboids. 
 
The reaction cross-section, as estimated from figure 3-11 and from the photon beam 
information provided by reference 45, is 1.29 x 10
-29
 cm
2
 per atom per photon.   
 
Considering a cube of bone of volume 1 cm
3
, and assuming equal absorption in all the 
layers (given the small cross section), the cross section is of the order of 10
-7
 per photon.   
Integrating this over the length of the cuboid, the cross section is of the order of 10
-6
 per 
photon. 
Taking the average energy of the 25 MV beam to be 8 MeV, the number of photons 
delivering 13 Gy is of the order of 10
10
 to 10
11
.   
This gives an estimated number of reactions in the order of 10
5
 to 10
6
.  So, the estimated 
number of positrons is of the order of 10
5
 to 10
6
 in magnitude. 
 
 
 
 
